PoreWise
✓ Human-reviewed

Cetaphil · Creams

Restoraderm Eczema Soothing Moisturizer

Compare Primary source · Verified

Product

Brand:
Cetaphil
Product type:
Creams
Last checked:
2026-10-12
Formula version:
Pack label · 2026-10-12
Fragrance & alcohol:
Fragrance-free · Alcohol-free

Product image from the brand page

Ingredient list coverage 85% Well covered

32 ingredients on this list · COLLOIDAL OATMEAL at number 1 · WATER at number 2 · GLYCERIN at number 3

Missing: every name identified

Product description

A moisturizer whose labelled active is 1.0% colloidal oatmeal. The inactive list leads with water and glycerin and includes ceramide NP.

Full ingredient list

Kept exactly as the source printed it, including spelling in the original.

  1. 1 COLLOIDAL OATMEAL Ambiguous
  2. 2 WATER
  3. 3 GLYCERIN
  4. 4 CAPRYLIC/CAPRIC TRIGLYCERIDE
  5. 5 HELIANTHUS ANNUUS (SUNFLOWER) SEED OIL
  6. 6 PENTYLENE GLYCOL
  7. 7 BUTYROSPERMUM PARKII (SHEA) BUTTER
  8. 8 CYCLOPENTASILOXANE
  9. 9 CETEARYL ALCOHOL
  10. 10 SORBITOL
  11. 11 BEHENYL ALCOHOL
  12. 12 GLYCERYL STEARATE
  13. 13 CETYL ALCOHOL
  14. 14 TOCOPHERYL ACETATE
  15. 15 ARGININE
  16. 16 NIACINAMIDE
  17. 17 GLYCERYL STEARATE CITRATE
  18. 18 SODIUM POLYACRYLATE
  19. 19 DISODIUM ETHYLENE DICOCAMIDE PEG-15 DISULFATE
  20. 20 CAPRYLYL GLYCOL
  21. 21 CETEARETH-20
  22. 22 SODIUM PCA
  23. 23 PANTHENOL
  24. 24 CITRIC ACID
  25. 25 ALLANTOIN
  26. 26 DIMETHICONOL
  27. 27 OPHIOPOGON JAPONICUS ROOT EXTRACT
  28. 28 DISODIUM EDTA
  29. 29 MALTODEXTRIN
  30. 30 SODIUM HYALURONATE
  31. 31 CERAMIDE NP
  32. 32 PANTOLACTONE
Spelling in the source: Collodial Oatmeal
Original label text
ACTIVE INGREDIENTS
Collodial Oatmeal 1.0%
INACTIVE INGREDIENTS
Water, Glycerin, Caprylic/Capric Triglyceride, Helianthus Annuus (Sunflower) Seed Oil, Pentylene Glycol, Butyrospermum Parkii (Shea) Butter, Cyclopentasiloxane, Cetearyl Alcohol, Sorbitol, Behenyl Alcohol, Glyceryl Stearate, Cetyl Alcohol, Tocopheryl Acetate, Arginine, Niacinamide, Glyceryl Stearate Citrate, Sodium Polyacrylate, Disodium Ethylene Dicocamide Peg-15 Disulfate, Caprylyl Glycol, Ceteareth-20, Sodium Pca, Panthenol, Citric Acid, Allantoin, Dimethiconol, Ophiopogon Japonicus Root Extract, Disodium Edta, Maltodextrin, Sodium Hyaluronate, Ceramide Np, Pantolactone

Ingredient analysis

NIACINAMIDE · Actives · NIACINAMIDE · Barrier lipids · GLYCERIN · Humectants

Actives

1

Ingredients added for a stated effect on the skin.

Barrier lipids

2

Lipids that occur naturally in the skin barrier (ceramides, cholesterol, fatty acids).

Humectants

5

Bind water and draw it into the upper layers of the skin.

Emollients

4

Fill the gaps between corneocytes to soften and smooth the surface.

Cleansing agents

1

Lift oil and dirt so they can be rinsed away with water.

Preservatives

1

Inhibit microbial growth so the product stays safe to use.

Soothing agents

2

Used to reduce the sensation of irritation or discomfort.

Chelating agents

2

Binds metal ions to keep the formula stable.

pH adjusters

1

Bring the formula to, and hold it at, its target pH.

Texture agents

3

Set the viscosity and feel of a formula.

Solvents

2

Dissolve or carry other ingredients.

Emulsifiers

4

Keep oil and water mixed in a stable formula.

Evidence

  • Skin effect Human trial Certainty: Moderate Primary source

    In a randomized, placebo-controlled split-face study of 30 healthy Japanese women, a cosmetic containing 4% niacinamide reduced the skin-surface average roughness (Ra) value significantly more than the niacinamide-free control site after 8 weeks (P<0.05).

    Who it applies to: Skin-surface roughness measured by replica profilometry (Ra).

    Study limits: Measured at the eye area on a photoaged/wrinkle cohort; the endpoint is surface roughness.

  • Skin effect Human trial Certainty: Moderate Primary source

    In 20 people with Fitzpatrick skin types IV-V, a broad-spectrum sunscreen containing sclareolide and niacinamide significantly prevented experimentally induced post-inflammatory hyperpigmentation: in stripped, exposed zones the protected skin improved by +5.96 ITA degrees versus -9.88 in unprotected skin (net protection about 16 ITA degrees, p < 0.001).

    Who it applies to: People with darker skin phototypes (IV-V) prone to post-inflammatory hyperpigmentation, applying the sunscreen daily for 20 days under UV and visible-light exposure.

    Study limits: Small sample (20), within-subject controlled model of experimentally induced pigmentation; the abstract calls for comparative studies with and; industry involvement.

  • Skin effect Human trial Certainty: Moderate Primary source

    In 72 women with visible signs of ageing, a niacinamide-containing biomimetic lamellar cream significantly improved the Cutometer R5 elasticity parameter, wrinkle score, TEWL and corneometer values over 4 weeks compared against the untreated side.

    Who it applies to: Women with visible signs of ageing, applying the cream twice daily for 4 weeks.

    Study limits: Grading of high-resolution images failed to detect improvements in skin texture; proof-of-concept studies.

  • Skin effect Human trial Certainty: Moderate Primary source

    In 91 women with melasma, a skincare routine containing vitamin B3 (niacinamide) and 2-mercaptonicotinyl glycine significantly reduced MASI after 3 months, with roughly 38-41% reduction by 6 months.

    Who it applies to: Women aged about 44 with melasma, phototypes III-IV, using the routine twice daily with daily SPF50+ sunscreen.

    Study limits: A clinically relevant difference favoured Kligman's triple combination in the first 3 months; industry-funded; skin radiance and fine wrinkles also improved.

  • Skin effect Human trial Certainty: Moderate Primary source

    In a randomized, double-blind, placebo-controlled split-face trial of 52 Taiwanese subjects, 4% niacinamide alone significantly reduced instrument-measured pore counts at week 8, and 4% niacinamide with 0.03% kinetin produced persistent significant reductions in pore, spot, wrinkle and evenness counts at weeks 8 and 12.

    Who it applies to: Instrument-measured facial pore counts over 8-12 weeks.

    Study limits: The niacinamide-group showed significant pore reduction at week 8; 'pore counts' is an instrument parameter.

  • Skin effect Human trial Certainty: Moderate Primary source

    In a double-blind, placebo-controlled trial of 100 Japanese subjects, a 2% niacinamide moisturiser significantly lowered sebum excretion rate after 2 and 4 weeks; in a separate 30-person Caucasian split-face study it significantly reduced casual sebum level after 6 weeks.

    Who it applies to: Adults with facial sebum concerns applying a 2% niacinamide moisturiser for 2 to 6 weeks; measured with sebumeter-based sebum excretion rate and casual sebum level.

    Study limits: The effect differs by measured endpoint and population.

  • Skin effect Human trial Certainty: Moderate Primary source

    In 40 people with mild-to-moderate acne all using topical benzoyl peroxide plus adapalene, a moisturiser with ceramides and niacinamide significantly improved non-inflammatory, inflammatory and total acne lesions on that side of the face versus a hydrophilic cream after 8 weeks, and decreased cutaneous irritation.

    Who it applies to: People on topical anti-acne medication who add a moisturiser alongside treatment, in a split-face, double-blind, randomized design for 8 weeks.

    Study limits: All participants used prescription/OTC anti-acne drugs (5% benzoyl peroxide + 0.1% adapalene). TEWL, hydration, sebum, pH and other biophysical measures stayed close between the two creams. This is adjunctive care.

  • Skin effect Human trial Certainty: Moderate Primary source

    In a 12-week randomized, double-blind half-face study, a combination of 4-hexylresorcinol and niacinamide improved hyperpigmentation spots (L*), the appearance of fine lines and wrinkles, and skin firmness significantly more than niacinamide alone.

    Who it applies to: Chinese adults using the combination cream twice daily for 12 weeks in a split-face design.

    Study limits: Industry-funded (Unilever R&D); part of the evidence comes from in-vitro melanocyte and 3D skin models.

  • Skin effect Human trial Certainty: Low Primary source

    A facial moisturiser containing niacinamide improved stratum corneum barrier function and skin hydration, measured instrumentally, in people with rosacea over four weeks of twice-daily use.

    Who it applies to: A leave-on facial moisturiser, applied twice daily for four weeks, in adults with rosacea.

    Study limits: The tested article was a finished moisturiser. Fifty participants, one centre, four weeks. The study measured barrier function and hydration.

  • Skin effect Human trial Certainty: Low Primary source

    In a randomized split-face controlled trial in people with rosacea-associated erythema and sensitive skin, a dermocosmetic containing mineralizing water, probiotic fractions, hyaluronic acid and niacinamide significantly improved erythema at day 15 (p<0.01) and day 30 (p<0.001), with skin erythema, tightness, dryness, hydration and TEWL improving versus the untreated side (p<=0.05).

    Who it applies to: Facial erythema, tightness, dryness, hydration and TEWL over 30 days.

    Study limits: The comparator is usual skin care / an untreated half-face.

  • Skin effect Human trial Certainty: Low Primary source

    In an open randomized, vehicle-controlled trial of 48 people with mild-to-moderate facial seborrheic dermatitis, 4% nicotinamide cream once daily for 12 weeks reduced the combined erythema/scaling/infiltration score by 75% from baseline versus 35% with the vehicle (p<0.05).

    Who it applies to: Combined clinical score of erythema, scaling and infiltration over 12 weeks.

    Study limits: Open-label.

  • Skin effect Human trial Certainty: Low Primary source

    In 30 women with melasma or post-inflammatory hyperpigmentation, a serum combining lotus sprout extract, tranexamic acid and niacinamide reduced skin tone unevenness by 38% and 33% respectively over 16 weeks (P < 0.008).

    Who it applies to: Women with melasma or PIH, 70% with Fitzpatrick skin types IV-VI, applying the serum twice daily for 16 weeks.

    Study limits: 30 participants; "skin tone unevenness" is a sponsor-defined endpoint.

  • Skin effect Human trial Certainty: Moderate Primary source

    In 88 women with sensitive skin, a face cream containing Centella asiatica leaf extract, ceramide NP and panthenol lowered the SS-10 symptom score by 66% at week 2 and 76% at week 4, with irritation, tautness, itching and redness all significantly reduced.

    Who it applies to: Chinese women with sensitive skin applying the cream to the whole face, followed up at day 2, weeks 1, 2 and 4.

    Study limits: Observational and self-controlled.

  • Skin effect Human trial Certainty: Moderate Primary source

    In a randomized, double-blind, vehicle-controlled split-body trial of 50 people with sensitive skin, an emollient containing Ceramide NP C15 significantly reduced transepidermal water loss in participants with an impaired skin barrier over 6 weeks.

    Who it applies to: People with sensitive skin applying the emollient in a split-body design for 6 weeks; the barrier improvement was clearest in those whose barrier was already impaired.

    Study limits: Exploratory; both the ceramide formulation and the vehicle improved subjective symptoms, and the significant TEWL reduction was seen specifically in the impaired-barrier subgroup.

  • Skin effect Human trial Certainty: Moderate Primary source

    In adults with mild-to-moderate xerosis (senile xerosis), a cream containing ceramides 1, 3, 6-II improved stratum corneum hydration, transepidermal water loss and skin pH more than a hydrophilic cream, measured at 24 hours and after 28 days of twice-daily use.

    Who it applies to: Leave-on moisturizers for dry skin. The study enrolled adults with mild-to-moderate xerosis.

    Study limits: Small single-site study (24 participants), split-site comparison on the shins, 28 days. It shows the tested formula outperformed a basic hydrophilic cream on measured skin parameters.

  • Skin effect Brand claim Certainty: High Public database

    Ceramides, cholesterol and fatty acids are the lipids that make up the skin barrier; formulations add them to replenish it.

    Who it applies to: Barrier function generally; the ratio between the three lipid classes matters in the literature.

    Study limits: Finding · CERAMIDE NP · Ceramide AP · Ceramide EOP

  • Skin effect Human trial Certainty: Moderate Primary source

    In a randomized, double-blind, four-arm crossover study of 51 healthy volunteers with dry skin, an emollient containing glycerol and petrolatum raised corneometry-measured skin moisture significantly above its vehicle (P < 0.0001) over 12 hours. The authors attributed the hydration gain to the glycerol component and the lower water loss to the petrolatum component.

    Who it applies to: Corneometry (skin moisture) and transepidermal water loss over 12 hours after one application.

    Study limits: Measured on the forearms. The significant hydration result comes from the full emollient containing both glycerol and petrolatum.

  • Skin effect Review article Certainty: Moderate Primary source

    Topical glycerol improves stratum corneum hydration, barrier function and skin mechanical properties. The review also reports reduced irritation response and faster wound healing, and traces the effect to aquaporin-3 transport and to glycerol's own presence in the skin.

    Who it applies to: Leave-on products. The review discusses both healthy skin and skin with dry or barrier-impaired conditions such as atopic dermatitis.

    Study limits: A narrative review. It compiles mechanisms and results from other studies.

  • Skin effect Official ingredient listing Certainty: High Public database

    Glycerin is classified as a humectant in cosmetic ingredient databases: its role in a formula is to hold water.

    Who it applies to: Cosmetic formulas generally. · Ingredient database · GLYCERIN

    Study limits: Skin effect of to the stratum corneum comes from a separate review of the literature. · Ingredient database · GLYCERIN

  • Skin effect Human trial Certainty: Moderate Primary source

    In 38 children with atopic dermatitis, a cream containing linoleic acid, 5% dexpanthenol and ceramide improved SCORAD significantly more than a 5% urea cream after 4 weeks (P = 0.043); both groups improved from baseline.

    Who it applies to: Children with mild-to-moderate atopic dermatitis applying the cream twice daily for 4 weeks in a randomised, double-blind, bilateral paired design.

    Study limits: Both interventions were non-prescription moisturisers: this is emollient / basic skin care. Small sample (37 completed); stratum corneum hydration and time to remission stayed close between groups.

  • Skin effect Human trial Certainty: Moderate Primary source

    In 110 people with facial sensitive skin, a cream containing panthenol used twice daily for 28 days significantly increased stratum corneum moisture and reduced erythema index, redness (a* value) and transepidermal water loss.

    Who it applies to: People with facial sensitive skin applying the cream twice daily for 28 days.

    Study limits: Panthenol was combined with prebiotics and a probiotic lysate.

  • Skin effect Human trial Certainty: Low Primary source

    After facial non-ablative fractional laser treatment, a panthenol mask lowered the erythema and pigmentation indices on days 3, 7 and 14 against a saline dressing, raised stratum corneum moisture, and reduced transepidermal water loss over the same days. Sebum content was also higher in the mask group on days 7 and 14.

    Who it applies to: Skin recovering from 1550 nm and 1927 nm non-ablative fractional laser on the face. Both groups received standard post-procedure care.

    Study limits: The mask also contained madecassoside and bisabolol. It is one trial of 60 people, all recovering from the same procedure, and the published grant list includes L'Oreal Dermatological Beauty China (La Roche-Posay).

  • Skin effect Human trial Certainty: Low Primary source

    In a randomized, investigator-blind, split-face trial of 40 Asian acne patients, a moisturizer containing 4-t-butylcyclohexanol, licochalcone A, ceramide and panthenol improved facial hydration more than a traditional moisturizer (p=0.001) and produced lower dryness scores (p=0.021) over 4 weeks.

    Who it applies to: Facial hydration and investigator-rated dryness over 4 weeks.

    Study limits: All participants were on prescription acne therapy (including oral isotretinoin), so the dryness is drug-induced; both sides used a moisturizer, so this is a comparison between two moisturisers; acne lesion counts decreased equally on both sides.

  • Sensitization Review article Certainty: Low Primary source

    Panthenol is treated as non-allergenic, this review argues that frequent exposure, especially on damaged skin, can produce hypersensitivity to it. The likely route is a delayed (type IV) contact reaction; immediate and mixed reactions remain possible. Proposes patch testing with the patient's own product and with panthenol 5% in petrolatum.

    Who it applies to: People who use panthenol products repeatedly, particularly those with atopic or damaged skin - the group the author says is most exposed.

    Study limits: A single-author narrative review. The mechanism it proposes is stated as likely. Read it as a reason to keep panthenol on the list of possible allergens.

  • Skin effect Human trial Certainty: Moderate Primary source

    All five 0.1% hyaluronic acid creams tested, from 50 kDa to 2000 kDa, raised skin hydration and overall elasticity above the vehicle cream applied to the other eye at 60 days.

    Who it applies to: 0.1% hyaluronic acid creams applied twice daily for 60 days to the eye area of women aged 30-60 with periocular wrinkles.

    Study limits: Sixty days, and the vehicle sat on the fellow eye. Hydration and elasticity were read by instruments. The volunteers were women aged 30-60 with eye-area wrinkles.

  • How deep it gets In vitro study Certainty: Moderate Primary source

    Hyaluronic acid of 20-300 kDa crossed the stratum corneum in excised human skin, while hyaluronic acid of 1000-1400 kDa remained in the stratum corneum.

    Who it applies to: Excised human skin with intact stratum corneum, measured by Raman micro-imaging after topical application.

    Study limits: One laboratory's imaging study. Three molecular-weight grades were tested. "remains above" describes intact stratum corneum in this ex vivo setup.

  • Skin effect Brand claim Certainty: Moderate Public database

    Hyaluronic acid and its salt bind water at the skin surface, giving a plumper look immediately after application.

    Who it applies to: Leave-on hydrating products.

    Study limits: The effect is largely surface and temporary. In dry air a humectant. · Finding · Sodium hyaluronate · Hydrolyzed hyaluronic acid

  • Irritation Review article Certainty: Low Primary source

    The CIR expert panel's 1985 assessment of stearyl alcohol reports minimal to mild cutaneous irritation in rabbit tests, and a very low order of irritation and sensitization in clinical patch testing. It concluded that stearyl alcohol is safe as used in cosmetics.

    Who it applies to: Stearyl alcohol, one of the two fatty alcohols that cetearyl alcohol is made of, at the use concentrations reported to the panel.

    Study limits: It assesses stearyl alcohol. It was published in 1985 and relies largely on data submitted by the ingredient trade association. "Very low order" is the panel's wording.

  • Pore clogging Animal study Certainty: Low Primary source

    In the rabbit ear-canal assay, the nine materials graded positive were eight esters (isopropyl palmitate, isopropyl myristate, butyl stearate, isopropyl isostearate, decyl oleate, isostearyl neopentanoate, isocetyl stearate, myristyl myristate) and cocoa butter.

    Who it applies to: Materials applied to the rabbit ear canal as raw ingredients.

    Study limits: An animal assay. The rabbit ear canal reacts more readily than human skin. The abstract names the positive group.

Related skin concerns

Skin concerns with evidence for ingredients on this list.

Formula history

1 version of this formula on record.

Related products